nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.418	0.602	CbGbCtD
Ximelagatran—CYP2C9—Progesterone—uterine cancer	0.277	0.398	CbGbCtD
Ximelagatran—F2—posterior vena cava—uterine cancer	0.214	0.7	CbGeAlD
Ximelagatran—F2—artery—uterine cancer	0.0384	0.126	CbGeAlD
Ximelagatran—F2—epithelium—uterine cancer	0.0146	0.0477	CbGeAlD
Ximelagatran—F2—renal system—uterine cancer	0.0135	0.0443	CbGeAlD
Ximelagatran—F2—female reproductive system—uterine cancer	0.0108	0.0355	CbGeAlD
Ximelagatran—F2—female gonad—uterine cancer	0.00984	0.0323	CbGeAlD
Ximelagatran—CYP2C9—female reproductive system—uterine cancer	0.00431	0.0141	CbGeAlD
